HempNewsBreaks – SinglePoint, Inc. (SING) Provides 2019 Recap, Outlook for 2020

SinglePoint (OTCQB: SING), a technology and investment company, this morning provided a recap of 2019 and outlook for 2020. The company exceeded $1,000,000 in revenue for Q3, making it its largest third quarter in company history. Moving forward, SING sees substantial growth in two major markets, hemp and solar, and is focused on growing within these market segments throughout the fourth quarter and into 2020. The company is launching its nicotine and tobacco free 1606 Original Hemp cigarettes at MJBIZCON taking place at the Las Vegas Convention Center December 11-13, 2019. SinglePoint expects the sale of 1606 to be a key contributor to overall company growth in 2020. “We have an exceptional strategic plan in making SinglePoint one of the biggest publicly traded companies in the smokable hemp space. We believe we offer investors and our current shareholders tremendous value given our leadership position in several explosive markets including ecommerce, Hemp and Solar. As SinglePoint continues to grow revenue and profit we continue to strive for meeting the qualifications to apply for a listed exchange,” SinglePoint CEO Greg Lambrecht stated in the news release.

To view the full press release, visit http://cnw.fm/Y0LVo

About SinglePoint Inc.

SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar renewables, Hemp and distribution tobacco products. SinglePoint is working to grow to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Advances Toward Nasdaq Exchange Uplisting

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today provided an update as it moves toward an uplisting of shares onto a major U.S. exchange following news that Sugarmade’s direct competitor, GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen”), announced on Monday, November 25, that its shares have been approved for listing on the Nasdaq Capital Market (“NASDAQ”). According to the update, company management believes that, following its strategic move to acquire BZRTH, Inc., as well as another acquisition to be announced in the near future, that Sugarmade is very similar to GrowGen, on an overall, consolidated basis, in terms of market segment, scale of operations and financial performance metrics. As a result, Sugarmade believes GrowGen’s move onto the Nasdaq is a very promising signal as the company prepares to uplist its own shares. “The approval of GrowGen shares for the move up onto the Nasdaq market is a great sign for Sugarmade as we prepare to make a similar move,” Sugarmade CEO Jimmy Chan said in the news release. “It’s a positive signal about the hydroponics market and about our overall strategy. It’s time for institutional investors to get heavily involved in the pick-and-shovel ancillary markets surrounding the hemp and hemp-related boom. GrowGen has done a great job, and we are hot on their tail right now, and plan to surpass them in the race to number one in the hydroponics space.”

To view the full press release, visit http://cnw.fm/c9uoE

About Sugarmade, Inc.

Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. The Company is becoming a leading supplier to the growing hemp industry and is benefitting from the growth of the hydroponic marketplace. The Company is in the process of acquiring several leading hydroponic and agricultural supply companies that are currently producing in excess of $70 million in annual revenues. Sugarmade is also an investor in fast growing Hempistry, Inc., a Kentucky-based cultivator of industrial hemp, and operates Carryoutsupplies.com a leader provider to the quick service restaurant industry. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant and sports business executive Rich Kleiman. According to the update, Thirty Five Ventures will collaborate with Canopy Rivers as it continues to pursue its global growth strategy and strengthen its global portfolio of leading cannabis companies. Canopy Rivers will also look to co-invest with Thirty Five Ventures on cannabis-related deals, leveraging the group’s expertise in brand development and marketing. “We’re thrilled to have Thirty Five Ventures join the Canopy Rivers team,” Narbé Alexandrian, president and CEO of Canopy Rivers, said in the news release. “Kevin Durant and Rich Kleiman have built an incredible brand worldwide, investing in and growing some of the cannabis and tech industry’s hottest companies. We’re excited to combine our venture capital knowledge and cannabis domain expertise, and we believe that this partnership will drive success for our portfolio as we continue to grow it in the years ahead.”

To view the full press release, visit http://cnw.fm/pw4Lf

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – VPR Brands LP (VPRB) Provides Update on Monetization, Enforcement of Electronic Cigarette Utility Patent

VPR Brands (OTCQB: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts (“CBD”), as well as electronic cigarettes containing nicotine, on Monday provided an update regarding the monetization and enforcement of its U.S. utility patent for electronic cigarettes. The company’s patented technology is one of the earliest filed electronic cigarette patents and includes two broad, independent claims encompassing products with an electric airflow sensor, including a sensor comprised of a diaphragm microphone. VPR Brands has begun identifying more than 50 infringing companies, based on sales volume, and has started notifying the companies of their infringement. Per the update, VPRB recently hired intellectual property (“IP”) law firm SRIPLAW to advise the company on monetization strategy and manage and execute the process. The company’s monetization strategy includes licensing and or manufacturing contracts with infringing brand owners. “Having personally been in the vape industry for the past 10 years and witnessing the evolution of e-Cig and vapor technology, it is befitting that our company owns this US utility patent for what has grown to be a multibillion-dollar market. The inner construction of an e-cigarette is quite simple and fairly standard and it is very obvious as to what our auto draw technology patent covers, and potential infringement is rather clear when you see it,” VPR Brands CEO Kevin Frija stated in the news release. “Our patent could be a huge windfall for the company either by enticing infringing companies to order product through VPR Brands or as an alternative pay royalty on infringing product. Infringement can be avoided by simply adding a button to the battery but there is a reason the preferred option by consumers and most manufactures to date to simulate real smoking is our buttonless auto draw technology which best mimics real smoking.”

To view the full press release, visit http://cnw.fm/Jb4YA

About VPR Brands, LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis and cannabidiol (“CBD”) through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – New Jersey Could Have the Lowest Weed Taxes According to Voter Measure

If everything goes according to plan, New Jersey could be the state with the lowest tax rate for legal weed sales. Voters are expected to vote on a marijuana legalization measure that seeks to allow the state to subject a sales tax of 6.625% on legal weed sales.

All cities allowing the sale of legal weed would be authorized to impose a maximum of 2% transfer tax which would total up to 8.625%. This would still be the lowest tax imposed on legal marijuana sales in the U.S.

According to marijuana analysts, the low taxes would enable legal marijuana to compete with and eventually eradicate the illicit weed market. The period in which New Jersey will be able to start implementing the low rate tax is uncertain.

According to the president of the New Jersey Cannabusiness Association, Scott Rudder, voter approval for recreational weed in the 2020 elections could lead to additional details such as Excise taxes.

Rudder also said that the ballot question should be detailed so that the voters can make an informed decision.

He was of the view that the new regulations would not be implemented until the voters approve the measure, and the tax proposals for the marijuana industry may still be altered.

Rudder also said other states might legalize marijuana and the desire to have common taxes in the Northeast states where marijuana is legal may force New Jersey to abandon its measure in favor of a collective position agreed upon with neighboring states.

New Jersey would be the only state not imposing an additional tax, such as excise tax, because all the other states that have legalized recreational marijuana impose some excise tax on legal weed sales, which amounts to about 26% when you add both sales and excise tax.

Washington has the highest percentage of tax on legal weed sales, whose average is 43%, while Michigan customers pay the lowest, at 16%.

States where weed is legal allow their cities to impose their additional taxes besides the general sales taxes imposed by the state.

The executive director of the National Organization of Marijuana Laws, Erik Altieri, said that there is a possibility that New Jersey will impose some excise tax by the time the first ounce of legal cannabis is sold. Altieri further noted that the state law would continue to evolve once marijuana is legalized.

Legalization of weed has been a topic for debate in the Legislature for the last two years and the proposed pot taxes have gone through many changes. State Senator Nicholas Scutari introduced a bill in the state Assembly which suggested for an increasing marijuana tax which would begin at 7% and rise to 25% over the next few years. The last bill proposed a $42 flat-rate fee per ounce, which equates to a 12% tax rate. This would ensure a steady source of revenue, even if the market price for marijuana drops.

Scutari said that removing the additional taxes is a sure way of fighting the black market because people would be more inclined to buy the cheap, safe, and high-quality weed from a licensed dispensary instead of purchasing from an illegal dealer.

These proposals seem good on paper, but experts say industry actors like SinglePoint Inc. (OTCQB: SING) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) have learnt that nothing is clearcut in New jersey, so they will only wait to see the final law which is cleared for implementation.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Key Congressional Committee Passes Marijuana Legalization Bill

On Wednesday, a key Congressional committee passed legislation that would decriminalize and tax marijuana as well as expunging federal marijuana convictions. However, to become law, it has to be approved by the full House and the Republican-controlled Senate. The House Judiciary Committee passed the bill by a vote of 24 to 10.

The bill is known as the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019 and was introduced by Rep. Jerrold Nadler (D-NY) and co-sponsored by more than 50 legislators. The legislation has the following provisions:

Remove weed from Schedule 1 of the Controlled Substance Act, which includes drugs such as heroin, fentanyl, and ecstasy.
Allow states to create their own marijuana policies, decriminalize low-level marijuana felonies, and seal the record for past federal convictions.
Create a Cannabis Justice Office that would impose a 5% tax on legal marijuana sales to fund job training, legal aid, and help people who are negatively affected by marijuana prohibition.

In a statement, Nadler said that the MORE Act has been long overdue. He further said that rather than handling marijuana as an issue of personal choice and public health, the government has been taking it as a criminal justice problem. Nadler asserted that it is unwise and unjust to federally arrest, prosecute and incarcerate people for using recreational or medical marijuana.

The Pew Research Center conducted a survey in November 2019 which revealed that more than two-thirds of American adults support the legalization of medical and adult-use marijuana. However, only 8% said that marijuana should remain illegal in all forms.

According to the National Conference of State Legislatures, currently, in the U.S., medical and recreational marijuana is legal in eleven states, including the District of Columbia, while medical marijuana is legal in 33 states.

Although the public is in favor of the bill, the majority of the Republicans are still on the fence about pursuing marijuana legalization.

On Wednesday, Colorado Republican and Committee member, Ken Buck said he is doubtful the Republicans will back this bill. He is almost sure that the Senate will not even consider it. Buck’s suggestion for the House is to deal with other measures that would get bipartisan support.

All 2020 presidential candidates, except the former Vice President Joe Biden, are in favor of marijuana legalization. Biden openly opposed marijuana legalization during the primary debates on Wednesday saying that more scientific research is needed to prove that it is not a “gateway drug.” Although the Centers for Disease Control agree with the need for further studies, the organization also noted that people who use weed do not proceed to use other hard drugs.

One can only imagine that marijuana companies like LiveWire Ergogenics Inc. (OTC: LVVV) and No Borders Inc. (OTC: NBDR) will only celebrate once the MORE Act is approved by Senate and signed into law by the President.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc.’s (CIIX) CBD Biotech Featured in Wall Street Journal Report on Growing Cannabis Industry in China

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands, was featured in a recent Wall Street Journal report. The report entitled “China Says No to Marijuana but Lets Its Cannabis Industry Bloom – Farmers, companies increase hemp-related investments; a push ‘at light speed’ into CBD business,” is dated November 13, 2019. “As one of the first movers in the legal industrial hemp skincare and cosmetics market, we are honored to be featured in this recent Wall Street Journal report and believe that this mention validates our efforts in China over the past few years,” CBD Biotech CEO Summer Yun said in the news release.

To view the full press release, visit http://cnw.fm/u54wM

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CBDW? Ask our Editor

CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Announces Q2 Results, Revenue Growth of 1,317% to Over $700K

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced financial results for its second quarter, which ended Sept. 30, 2019. Among the highlights, the company reported consolidated quarterly revenue growth of 1,317% to $707K compared to the same period last year, as well as cash and cash equivalents up 205% over the past six-month period to $228K. “Q2 ushered in a new standard across all top-line metrics and we expect to continue expanding on this growth through Q3 and beyond,” Cannabis Strategic Ventures CEO Simon Yu said in the news release. “Over the last two years, we have secured and invested capital to help drive revenue and substantially increase the Company’s total assets while improving gross profit margins. We expect continued growth to the top-line along with a declining drop in net losses next year.”

To view the full press release, visit http://cnw.fm/oDet7

About Cannabis Strategic Ventures

Cannabis Strategic Ventures Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Receipt of Conditional Approval to List on the Toronto Stock Exchange

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced its receipt of conditional approval from the Toronto Stock Exchange (the “TSX”) to list its common shares on the TSX. According to the update, final approval of the listing is subject to Willow Biosciences meeting certain TSX customary conditions, and Willow will issue a statement upon TSX’s confirmation of the commencement date. “Listing on the TSX is a significant milestone for Willow. The TSX will broaden our investment appeal and leave us well positioned to execute on our strategic initiatives for 2020 and beyond,” Willow President and Chief Executive Officer Trevor Peters said in the news release. “We are excited to add this to our 2019 accomplishments for Willow, which has seen us complete a go-public transaction, raise $37 million in a private placement and subsequent warrant exercise, enter into a potentially game-changing strategic partnership with Noramco, Inc., build out three state-of-the-art laboratories and continue to advance our cannabidiol producing yeast strain towards scale-up expected in the first half of 2020. Willow is uniquely positioned as one of the few public pure-play synthetic biology companies in the world targeting the potentially massive consumer packaged goods and pharmaceutical industries, and being listed on the TSX helps to increase our exposure to global investors.”

To view the full press release, visit http://cnw.fm/W0APt

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – No Borders Inc. (NBDR) Announces $3M Reg A Offering Qualification and Subsidiary’s First Publicly-Accessible Blockchain Product, CBD Lab Chain

No Borders (OTC: NBDR) today announced it has received “qualification” of its Reg A offering with the SEC to raise up to $3 million. According to the update, No Borders received only a single comment back from the SEC during the Reg A review process and has subsequently filed state registrations in Colorado, New York and Florida. “After nearly two years of work, several brands launched and over a million dollars of private capital invested into the No Borders journey, we are proud to offer our interested parties, big and small, an opportunity to invest with our amazing Company!” NBDR COO Cynthia Tanabe said in the news release. “For the first time since our merger in March 2018, No Borders can provide our supporters – both accredited and non-accredited investors – with a way to invest directly in the Company.”

In addition, on Nov 21, 2019, No Borders Labs announced its first publicly-accessible blockchain product, CBD Lab Chain. Per the update, the product brings together several current-generation technologies to provide a consumer-viewable access point to laboratory CBD and THC concentration test results for retail CBD products. No Borders Labs leverages the blockchain principle of transparency and creates a continuous revenue stream by charging CBD manufacturing and retailers, on a per-test basis, to post results to Lab Chain.

To view the full press releases, visit http://cnw.fm/iWMC5 and http://cnw.fm/p1LD1

About No Borders, Inc.

No Borders Inc. (OTC:NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority across its portfolio of assets. The Company’s portfolio of subsidiaries includes but is not limited to:

No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets (NoBordersNaturals.com).
No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (MediDentSupplies.com).
No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency (NoBordersLabs.com).

No Borders is headquartered in Arizona with resources in the USA, South America, Asia and Europe. For more information, visit www.NBDR.co.

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CBDW? Ask our Editor

CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.